Acurx Pharmaceuticals, Inc.
ACXP· Nasdaq
ACXPAcurx Pharmaceuticals, Inc.
Quarterly figures for Acurx Pharmaceuticals, Inc., with source filings when available.
26 quarters. Mar 31, 2020 to Jun 30, 2026. mixed units.
Acurx Pharmaceuticals, Inc. has filed its 10-Q within 39 to 44 days of period end across its last 8 quarters. The 10-K runs 71 to 76 days.
Acurx Pharmaceuticals, Inc. · CIK 1736243 · Engraved from SEC EDGAR
| Mar 31, 2026 |
| — |
| May 11, 2026 |
| 41 d |
| 10-Q |
| — |
| — |
| -$0.62 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | — | Mar 12, 2026 | 71 d | 10-K | — | — | — | |
| Q3 2025 | Sep 30, 2025 | — | Nov 12, 2025 | 43 d | 10-Q | — | — | -$1.23 | |
| Q2 2025 | Jun 30, 2025 | — | Aug 11, 2025 | 42 d | 10-Q | — | — | -$1.89 | |
| Q1 2025 | Mar 31, 2025 | — | May 12, 2025 | 42 d | 10-Q | — | — | -$2.15 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | — | Mar 17, 2025 | 76 d | 10-K | — | — | — | |
| Q3 2024 | Sep 30, 2024 | — | Nov 12, 2024 | 43 d | 10-Q | — | — | -$3.45 | |
| Q2 2024 | Jun 30, 2024 | — | Aug 8, 2024 | 39 d | 10-Q | — | — | -$5.21 | |
| Q1 2024 | Mar 31, 2024 | — | May 14, 2024 | 44 d | 10-Q | — | — | -$0.28 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | — | Mar 15, 2024 | 75 d | 10-K | — | — | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 13, 2023 | 44 d | 10-Q | — | — | -$0.24 | |
| Q2 2023 | Jun 30, 2023 | — | Aug 11, 2023 | 42 d | 10-Q | — | — | -$0.28 | |
| Q1 2023 | Mar 31, 2023 | — | May 12, 2023 | 42 d | 10-Q | — | — | -$0.25 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | — | Mar 15, 2023 | 74 d | 10-K | — | — | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 10, 2022 | 41 d | 10-Q | — | — | -$0.32 | |
| Q2 2022 | Jun 30, 2022 | Jul 25, 2022 · pre-market | Aug 12, 2022 | 43 d | 10-Q | — | — | -$0.26 | |
| Q1 2022 | Mar 31, 2022 | — | May 10, 2022 | 40 d | 10-Q | — | — | -$0.26 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | — | Mar 16, 2022 | 75 d | 10-K | — | — | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 12, 2021 | 43 d | 10-Q | — | — | -$0.46 | |
| Q2 2021 | Jun 30, 2021 | — | Aug 13, 2021 | 44 d | 10-Q | — | — | -$0.57 | |
| Q1 2021 | Mar 31, 2021 | — | — | — | — | — | — | -$0.21 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | — | — | — | — | — | — | |
| Q3 2020 | Sep 30, 2020 | — | — | — | — | — | — | -$0.21 | |
| Q2 2020 | Jun 30, 2020 | — | — | — | — | — | — | -$0.15 | |
| Q1 2020 | Mar 31, 2020 | — | — | — | — | — | — | — | |
